WallStreetZenWallStreetZen

NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?

Insider buying vs selling

Have Neurosense Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NRSN insiders and whales buy or sell their stock.

NRSN Shareholders

What type of owners hold Neurosense Therapeutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Meitav Investment House Ltd 10.62%95,000$127.30kInstitution
Hrt Financial LP0.09%13,998$18.76kInstitution
Scientech Research LLC0.08%12,584$16.86kInstitution
Geode Capital Management LLC0.08%11,963$16.03kInstitution
Ubs Group Ag0.04%5,496$7.36kInstitution
Morgan Stanley0.01%1,500$2.01kInstitution
Cwm LLC0.01%1,000$1.34kInstitution
Qube Research Technologies Ltd0.00%54$72.36Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

NRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRSN0.92%0.00%
BIVI3.68%96.32%Net Selling
VINC45.80%53.71%Net Buying
AKTX0.00%55.06%
INDP7.05%84.59%Net Buying

Neurosense Therapeutics Stock Ownership FAQ

Who owns Neurosense Therapeutics?

Neurosense Therapeutics (NASDAQ: NRSN) is owned by 0.92% institutional shareholders, 0.00% Neurosense Therapeutics insiders, and 99.08% retail investors. Meitav Investment House Ltd 1 is the largest individual Neurosense Therapeutics shareholder, owning 95,000.00 shares representing 0.62% of the company. Meitav Investment House Ltd 1's Neurosense Therapeutics shares are currently valued at $119.70k.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.